B1+ Inhomogeneity Correction for Estimation of Pharmacokinetic Parameters through an Approximation Approach
Xinran Zhong1,2, Novena Rangwala1, Steven Raman1, Daniel Margolis1, Holden Wu1,2, and Kyunghyun Sung1,2

1Radiological Sciences, University of California, Los Angeles, Los Angeles, CA, United States, 2Physics and Biology in Medicine, University of California, Los Angeles, Los Angeles, CA, United States

Synopsis

A simplified version of the B1+ correction method using an approximation model was proposed for estimation of pharmacokinetic modeling parameters. The proposed method was evaluated in both simulation and in vivo DCE-MRI data, and was applied to DCE-MRI with 63 suspicious lesions from two MRI systems to investigate B1+ induced errors in Ktrans. Significant difference of estimated Ktrans distributions was observed between two systems, showing it's necessary to perform B1+ correction for DCE-MRI analysis between systems.

Purpose

Quantitative dynamic contrast-enhanced MRI (DCE-MRI) has shown great promise for detection and grading of prostate cancer. Pharmacokinetic (PK) analysis is a powerful tool that provides quantitative assessment for contrast uptake in DCE-MRI, however, B1+ inhomogeneity, leading to flip angle (FA) variation, can introduce considerable errors into quantification, especially at 3.0T 1. It is shown that B1+ variation in the prostate is around 10-15% at 3.0T 2, and several studies showed the influence of B1+ inhomogeneity on PK parameters, such as Ktrans, ve and kep 1. However, the conventional B1+ correction approach typically includes complex mathematical calculation and modeling, limiting its practical application. In this work, we present a simplified and practical approach that corrects B1+ errors in quantitative DCE-MRI. We investigate the error propagation from FA variation to the PK analysis using numerical simulation and evaluate the correction of B1+-induced PK estimation errors in a total of 63 suspicious lesions of prostate cancer across two different MRI systems.

Methods

As demonstrated in Fig. 1, conventional B1+ correction requires a series of quantification steps with updated parameters based on FA variation. This B1+ correction approach can be non-trivial particularly when the entire PK modeling processing is not fully accessible (e.g, using a commercialized CAD software), limiting the practical application of B1+ correction for various DCE-MRI analysis.

In standard Tofts modeling3 with a population-averaged arterial input function (AIF)4, the B1+ correction can be simplified using Taylor series approximations under certain conditions: 1) small FA, 2) small TR/T10 ,and 3) k ≈ 1, where T10 is pre-contrast T1 and k reflects B1 inhomogeneity calculated by FA'/FA. Provided these conditions are satisfied, we can express the B1+ correction process as 1) Ktrans'/Ktrans ≈ k2, 2) ve'/ve ≈ k2, and 3) kep'/kep ≈ 1, where FA, Ktrans, ve and kep are original values and FA’, Ktrans’, ve’ and kep’ are B1+ corrected values. Note that the proposed model now becomes independent of T10, Ktrans, ve, and kep, enabling the direct B1+ correction of PK parameters without re-initiating pixel-by-pixel PK analysis.

We first evaluated the proposed correction model by measuring differences between conventional and proposed B1+ correction using numerical simulation. The simulation was performed with 100 k values (0.7-1.3) for 27 combinations of representative Ktrans, ve and T10 values (Ktrans=0.5, 1.2, 2.5 min-1, ve=0.3, 0.5, 0.7 and T10=1500, 2000, 2500ms)5. Imaging Parameters are assumed following clinical protocols (FAVFA = 2°, 5°, 10°, 15°, FADCE = 12°, TR = 4ms).

With IRB approval, the proposed correction model was retrospectively applied to 63 suspicious lesions from 43 clinically-indicated prostate MRI exams to investigate the B1+ influence in Ktrans across two 3.0T MRI scanners (Skyra and Trio, Siemens). A sub-cohort of nine cases were also used for further evaluation of the proposed correction model. B1+ maps were measured using reference region variable flip angle (RR-VFA) method6,7, and regions of interest (ROIs) were manually drawn on both prostate and suspicious lesions according to radiology reports (Fig. 2). RF transmission modes differed between two scanners: Skyra was operated with “TrueForm” RF transmission (n=51) and Trio was operated with circular polarization (n=12)8. T-tests were performed to evaluate the difference.

Results and Discussion

The simulation results (Fig. 3) show that conventional and proposed methods are close to identical, indicating that the difference between the two procedures is minimal. Within a range of k between 0.7-1.3, the maximum relative error was 0.61% for Ktrans'/Ktrans and 0.64% for ve'/ve, negligible compared to error introduced by B1+ inhomogeneity. With nine DCE-MRI cases, the in-vivo results also confirm the approximation error of the proposed model is negligible (0.87±0.08 % in the prostate and 0.95±0.07 % in suspicious lesions), as shown in Fig 2F.

The B1+, T10 and ΔKtrans (defined as original Ktrans - corrected Ktrans) in suspicious lesions were compared between two MRI scanners (Fig. 4). Due to the different B1+ inhomogeneity patterns, both T10 and ΔKtrans show different distributions across two MRI scanners. T10 inconsistency between two systems is effectively reduced after the B1+ correction (puncorrected =2.88×10-6, pcorrected=0.81). B1+-induced Ktrans errors are also distinctively different (p = 2.21×10-4) between two systems, which could be a critical problem when comparing parameters between systems and suggests that B1+ correction is essential for quantitative DCE-MRI analysis.

Conclusion

A simple approximation method is proposed to provide practical solutions for B1+ correction in quantitative DCE-MRI. The proposed model was evaluated by simulation and in-vivo data, and the approximation-induced error was shown to be negligible relative to the conventional method. Inconsistent B1+-induced Ktrans error distributions between systems were observed, indicating the necessity of B1+ correction for PK analysis.

Acknowledgements

Research reported in this abstract is supported by Siemens Medical Solutions.

References

[1] Azlan, Che A., et al. B1 transmission-field inhomogeneity and enhancement ratio errors in dynamic contrast-enhanced MRI (DCE-MRI) of the breast at 3T. Journal of Magnetic Resonance Imaging 31.1 (2010): 234-239.

[2] Zhong, Xinran, et al, Clinical Assessment of B1+ Inhomogeneity Effects on Quantitative Prostate MRI at 3.0 T, ISMRM, 2015 #1159

[3] Tofts, Paul S., et al. Estimating kinetic parameters from dynamic contrast-enhanced T 1-weighted MRI of a diffusible tracer: standardized quantities and symbols. Journal of Magnetic Resonance Imaging 10.3 (1999): 223-232.

[4] Parker, Geoff JM, et al. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magnetic Resonance in Medicine 56.5 (2006): 993-1000.

[5] Hayes, Carmel, Anwar R. Padhani, and Martin O. Leach. Assessing changes in tumor vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR in Biomedicine 15.2 (2002): 154-163.

[6] Sung, Kyunghyun, et al. Simultaneous T1 and B1+ Mapping Using Reference Region Variable Flip Angle Imaging. Magnetic Resonance in Medicine 70.4 (2013): 954-961

[7] Rangwala, Novena, et al. Validation of Variable Flip Angle Imaging-Based Simultaneous B1+ and T1 Mapping in the Prostate at 3T, ISMRM, 2015, #0492

[8] Blasche M, Riffel P, Matthias L. TimTX TrueShape and syngo ZOOMit Technical and Practical Aspects. MAGNETOM Flash 2012:74–84.

Figures

Fig.1 Flowchart comparison between conventional correction method and proposed correction method

Fig.2 An example of ROI analysis for in-vivo data (a) radiology report (b) high-resolution T2-weighted image to locate prostate (white) and lesions (green) (c) B1+ map (k value map) (d) original Ktrans map (e) relative error from B1+ inhomogeneity (f) relative error from proposed approximation

Fig. 3 A representative simulation results of ve and Ktrans.

Ktrans = 1.2min-1, ve = 0.5, T10 = 2500ms.


Fig. 4 Comparison of parameters between two systems: Trio (n = 12), Skyra (n = 51) and corresponding t-test results



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
2491